Pittsburgh Pharmacogenomics

Latest

ABCD-GENE score and bleeding in post-PCI patients: Implications for guided de-escalation of antiplatelet therapy

Coons JC, Polkowski K, Prebehalla L, Smith AC, Empey PE.

Genetic Testing for APOL1 in Adults With Hypertension: The GUARDD-US Randomized Clinical Trial

Eadon MT, Cavanaugh KL, She L, Steen-Burrell KA, Mohottige D, Nadkarni GN, Kitzman H, Chakraborty H, Empey PE, Limdi NA, Singh R, Beasley CM, Parker AS, Cicali EJ, Ramos MA, Clermont S, Dodgen L, Elwood EN, Robinson M, Umeukeje EM, Garcia Ortega A, Shroff N, Rosenman MB, Nguyen KA, Volpi S, Rider R, Dexter PR, Skaar TC, Peterson JF, Cavallari LH, Johnson JA, Wyatt CM, Orlando LA, Cooper-DeHoff RM, Horowitz CR.

VA renews partnership with Pitt Pharmacy to train its nationwide workforce to implement pharmacogenomics in practice

VA renews partnership with Pitt Pharmacy to train its nationwide...

Tanya Fabian selected as a 2026 Fellow of AAPP

Tanya Fabian selected as a 2026 Fellow of AAPP...

Philip Empey leads the R. Rodney Howell Symposium at ACMG 2026

https://pgx.pitt.edu/publications//...

Philip Empey appointed to inaugural steering committee for ASHP’s Center for Next-Generation Therapeutics

Philip Empey appointed to inaugural steering committee for ASHP’s Center...

Multi-site investigation of strategies for the implementation of CYP2C19 genotype-guided antiplatelet therapy

Empey PE, Stevenson JM, Tuteja S, Weitzel KW, Angiolillo DJ, Beitelshees AL, Coons JC, Duarte JD, Franchi F, Jeng LJB, Johnson JA, Kreutz RP, Limdi NA, Maloney KA, Owusu Obeng A, Peterson JF, Petry N, Pratt VM, Rollini F, Scott SA, Skaar TC, Vesely MR, Stouffer GA, Wilke RA, Cavallari LH, Lee CR; for the NHGRI Implementing GeNomics In PracTicE (IGNITE) Network.

The “All of Us” research program

All of Us Research Program Investigators.

Advanced pharmacy practice experiences in pharmacogenomics offered by US pharmacy programs

Gammal RS, Nguyen J, Audi E, Lee YM, Petry N, Empey PE.

Whole-genome sequencing as an investigational device for return of hereditary disease risk and pharmacogenomic results as part of the All of Us Research Program.

Venner E, Muzny D, Smith JD, Walker K, Neben CL, Lockwood CM, Empey PE, Metcalf GA, Kachulis C, Mian S, Musick A, Rehm HL, Harrison S, Gabriel S, Gibbs RA, Nickerson D, Zhou AY, Doheny K, Ozenberger B, Topper SE, Lennon NJ.